Legal News

Life Sciences weekly highlights—24 September 2020

Life Sciences weekly highlights—24 September 2020
Published on: 24 September 2020
Published by: LexisPSL
  • Life Sciences weekly highlights—24 September 2020
  • In this issue:
  • Brexit
  • Life sciences post-Brexit developments
  • Coronavirus (COVID-19)
  • ICO sets out its regulatory work on NHS COVID-19 app amid the coronavirus (COVID-19)
  • Coronavirus (COVID-19)—EMA green lights use of dexamethasone as treatment
  • EFPIA responds to State of the Union address amid coronavirus (COVID-19)
  • EU Parliament demands EU become more medically self-sufficient amid coronavirus (COVID-19)
  • FDA updated guidance on Clinical Trials of Medical Products during coronavirus (COVID-19)
  • More...

Article summary

This week's edition of Life Sciences weekly highlights includes a practical digest of action points provided by Sidley Austin LLP based on the collection of post-transition Brexit guidance published by the MHRA, the latest coronavirus (COVID-19) developments and the EMA’s report on a ten-year analysis of EU public health incident management that concludes its regulatory system has been a success. or take a trial to read the full analysis.

Popular documents